Novel Imaging Markers for Rheumatoid Arthritis

CompletedOBSERVATIONAL
Enrollment

30

Participants

Timeline

Start Date

October 31, 2013

Primary Completion Date

March 31, 2018

Study Completion Date

March 31, 2018

Conditions
Rheumatoid Arthritis
Interventions
DRUG

Cimzia

"For the loading phase, it consists of the first 3 doses. During the loading phase, the recommended dose of Cimzia for adults with rheumatoid arthritis is 400mg initially followed by 400mg again at week 2 and week 4. A 400mg dose requires 2 subcutaneous injection of 200mg; the injections should occur at separate sites in the thigh or abdomen.~After the loading dose, will be follow with 200mg every other week. The injection should occur at either the thigh or abdomen."

DEVICE

Magnetic Resonance Imaging (MRI)

MRI of the dominant wrist, before, during and after the gadolinium contrast injection will be acquired. The dose of the gadolinium agent for this study is 0.1mmol/kg body weight. This gadolinium contrast agent will increase the image contrast in the joints in the wrist and surrounding tissues and will make the MRI pictures stand out better.

DEVICE

High-resolution peripheral quantitative computed tomography (HR-pQCT)

HR-pQCT scan of the hand and wrist will be acquired to look at the bone quality. The scan uses special x-ray equipment to make detailed pictures of bone structure.

Trial Locations (1)

94107

UCSF - China Basin Imaging Center, San Francisco

All Listed Sponsors
lead

University of California, San Francisco

OTHER

NCT01773681 - Novel Imaging Markers for Rheumatoid Arthritis | Biotech Hunter | Biotech Hunter